ArticleCancers2022

Identification of Tumor Antigens and Immune Subtypes for the Development of mRNA Vaccines and Individualized Immunotherapy in Soft Tissue Sarcoma.

Changwu Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.